| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accurate Diagnosis and Appropriate Treatment Beneficial for HRS and AIH
|
Lederman, Lynne
|
|
2014
|
|
48 |
p. 28-29
|
artikel
|
| 2 |
Combination DCV/SOF is Effective in Achieving Sustained Response in Patients with HCV GT-3
|
Vinall, Maria
|
|
2014
|
|
48 |
p. 12-13
|
artikel
|
| 3 |
Current and Soon-to-Be-Approved Regimens Offer High Cure Rates for HCV
|
Lederman, Lynne
|
|
2014
|
|
48 |
p. 30-31
|
artikel
|
| 4 |
Current Perspectives on LDLT
|
Parry, Nicola
|
|
2014
|
|
48 |
p. 4-5
|
artikel
|
| 5 |
DCV/ASV/BCV Improves Sustained Viral Response in Patients with Chronic HCV GT-1 Infection and Compensated Cirrhosis: UNITY-2 Results
|
Vinall, Maria
|
|
2014
|
|
48 |
p. 11-12
|
artikel
|
| 6 |
Direct-Acting Antiviral Therapy Produces High SVR12 in HCV GT-1 Cirrhotic Patients Regardless of Baseline Characteristics
|
Hoyle, Brian
|
|
2014
|
|
48 |
p. 18-19
|
artikel
|
| 7 |
HCV—Infected Patients with Compensated Cirrhosis Benefit from 12-Week, Once-Daily, Oral Combination of LDV and SOF
|
Hoyle, Brian
|
|
2014
|
|
48 |
p. 21-21
|
artikel
|
| 8 |
High Efficacy Rates with Grazoprevir Plus Elbasvir in HCV Monoinfection and HCV/HIV Coinfection
|
Rizzo, Toni
|
|
2014
|
|
48 |
p. 23-24
|
artikel
|
| 9 |
Interferon- and RBV-Free Treatment with LDV and SOF is Efficacious in Patients Coinfected with HCV and HIV
|
Hoyle, Brian
|
|
2014
|
|
48 |
p. 25-25
|
artikel
|
| 10 |
Myrcludex B Therapy Reduced HBV DNA and HDV RNA in Phase 2a Clinical Trial
|
Rizzo, Toni
|
|
2014
|
|
48 |
p. 19-20
|
artikel
|
| 11 |
New Treatments for Hepatitis C
|
Hoyle, Brian
|
|
2014
|
|
48 |
p. 26-27
|
artikel
|
| 12 |
Prednisolone but Not PTX Improves 28-Day Mortality in Patients with Alcoholic Hepatitis
|
Vinall, Maria
|
|
2014
|
|
48 |
p. 10-11
|
artikel
|
| 13 |
Rapid Sustained HCV Viral Load Reductions Achieved with ACH-3102 Plus SOF
|
Rizzo, Toni
|
|
2014
|
|
48 |
p. 9-10
|
artikel
|
| 14 |
Sebelipase Alfa Normalizes ALT and Multiple other Disease-Related Abnormalities in Patients with LAL-D
|
Vinall, Maria
|
|
2014
|
|
48 |
p. 14-15
|
artikel
|
| 15 |
SOF Plus GS-5816 Effective in Noncirrhotic Patients Infected with HCV GT-3: ELECTRON-2 Final Results
|
Hoyle, Brian
|
|
2014
|
|
48 |
p. 13-14
|
artikel
|
| 16 |
SOF Plus GS-5816 Effective in Noncirrhotic, Treatment-Naïve Patients Infected with HCV Genotypes 1 to 6
|
Hoyle, Brian
|
|
2014
|
|
48 |
p. 17-17
|
artikel
|
| 17 |
Sustained Virologic Response of 91% in Patients Infected with HCV Treated with DCV-TRIO
|
Rizzo, Toni
|
|
2014
|
|
48 |
p. 15-16
|
artikel
|
| 18 |
SVR after Treatment of HCV Genotype 1a with ABT-450/Ritonavir, Ombitasvir, and Dasabuvir is Enhanced by RBV in Noncirrhotic Patients and by Extension of Duration in Cirrhotic Patients
|
Hoyle, Brian
|
|
2014
|
|
48 |
p. 20-21
|
artikel
|
| 19 |
100% SVR with Ledipasvir/Sofosbuvir Plus Ribavirin in Patients with HCV GT-1 Failing Prior Therapy
|
Rizzo, Toni
|
|
2014
|
|
48 |
p. 22-22
|
artikel
|
| 20 |
Terlipressin and Albumin Combination Therapy Improves Renal Function in HRS-1
|
Parry, Nicola
|
|
2014
|
|
48 |
p. 17-18
|
artikel
|
| 21 |
Uniform Downstaging Protocol Produces Excellent Posttransplantation Outcomes in HCC
|
Parry, Nicola
|
|
2014
|
|
48 |
p. 16-17
|
artikel
|
| 22 |
Use of Molecular Biology for Identifying Benign Hepatocellular Tumors Leads to More Personalized Medicine
|
Vinall, Maria
|
|
2014
|
|
48 |
p. 6-8
|
artikel
|
Tijdschrift beschrijving